MedTrace Logo

Immediate-access Arteriovenous Versus Standard Arteriovenous Grafts in Hemodialysis Patients

NCT04388397 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 477

Last updated 2020-07-23

No results posted yet for this study

Summary

Arteriovenous fistulae (AVF) are considered the main access for hemodialysis (HD). Arteriovenous grafts (AVGs) are an alternative access modality in patients with exhausted native venous access. Immediate-access arteriovenous grafts (IAAVGs) is a new modality in which dialysis can be started immediately to avoid complications of central venous catheters.

Conditions

  • Hemodialysis Access Failure

Interventions

PROCEDURE

Arteriovenous Grafts

Arteriovenous fistulae (AVF) are considered the main access for hemodialysis (HD). Arteriovenous grafts (AVGs) are an alternative access modality in patients with exhausted native venous access. Immediate-access arteriovenous grafts (IAAVGs) is a new modality in which dialysis can be started immediately to avoid complications of central venous catheters.

Sponsors & Collaborators

  • Egyptian Biomedical Research Network

    lead NETWORK

Principal Investigators

  • Ahmed Tawfik, PhD · Faculty of Medicine, Zagazig University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-15
Primary Completion
2020-04-10
Completion
2020-04-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04388397 on ClinicalTrials.gov